CIK 0001984086 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Septerna, Inc.
Sign in to watch- Ticker
- SEPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843891440
- Phone
- 650-338-3533
- Business address
- 250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale Director sold 81,820 shares at an average $48.09 ($3,934,363)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Planned sale President and COO sold 4,000 shares at an average $37.41 ($149,644)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, Drug Discovery sold 3,333 shares at $37.83 ($126,078)
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale 10% owner sold 147,200 shares at an average $50.27 ($7,399,858)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 1,493,000 shares at $42.50 ($63,452,500)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale President and COO sold 25,000 shares at $44.00 ($1,100,000)
- 144 Insider Sale of Securities
Page 1 of 9 · 176 filings